The Diagnostic and Prognostic Potentials of Non-Coding RNA in Cholangiocarcinoma

Abstract excerpt

Cholangiocarcinoma (CCA) is a rare biliary tract tumor with high malignancy. CCA is the second most common primary hepatobiliary cancer after hepatocarcinoma. Despite its rarity, the incidence of CCA is steadily increasing globally. Most patients with CCA are asymptomatic in the early stages, resulting in a late-stage diagnosis and poor prognosis. Finding reliable biomarkers is essential to improve CCA's early...

Topics

Join the communities discussing this publication.

• Cancer-related molecular mechanisms research
• Cholangiocarcinoma and Gallbladder Cancer Studies
• RNA modifications and cancer